📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: GlycoVaxyn

1.1 - Company Overview

GlycoVaxyn Logo

GlycoVaxyn

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology, developing and manufacturing immunogenic glycoprotein conjugate vaccines for a range of bacterial diseases, including pneumococcal and nosocomial infections.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to GlycoVaxyn

Inhibikase Therapeutics Logo

Inhibikase Therapeutics

HQ: United States Website
  • Description: Provider of cellular Abelson tyrosine kinase inhibitor therapeutics and platforms for infections and other diseases. Includes Risvodetinib (IkT-148009), an oral drug aimed at halting and reversing Parkinson’s progression in brain and GI; IkT-001Pro, a prodrug of imatinib mesylate for blood and stomach cancers with fewer on-dosing side effects; IkT-01427 to prevent PML; and the RAMP Drug Innovation Engine and Prodrug Delivery Technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inhibikase Therapeutics company profile →
Ondine Biomedical Logo

Ondine Biomedical

HQ: Canada Website
  • Description: Provider of non-antibiotic, anti-infective therapies for bacterial, viral, and fungal infections, including Steriwave nasal decolonization that eradicates pathogens in minutes (MRSA, SARS-CoV-2), Photodisinfection using a photosensitive agent and non-thermal laser light to destroy pathogens without resistance, and an Expanded Access Program for investigational medicines prior to regulatory approval.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ondine Biomedical company profile →
Quick-Med Technologies Logo

Quick-Med Technologies

HQ: United States Website
  • Description: Provider of proprietary, broad-based life sciences technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Quick-Med Technologies company profile →
SOM Biotech Logo

SOM Biotech

HQ: Spain Website
  • Description: Provider of AI-based drug discovery and drug repurposing for orphan CNS diseases via the SOM AI PRO platform, validated by two successful Phase 2 trials (TTR amyloidosis; chorea in Huntington’s). Pipeline includes SOM3355 (oral VMAT2 inhibitor, Phase 2b), SOM0226 (TTR stabilizer, outlicensed), SOM1311 (PKU chaperone, expected to enter Phase 2a in 2024), and SOM0034 (DMD program, Phase 2 expected 2025).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SOM Biotech company profile →
Humanigen Logo

Humanigen

HQ: United States Website
  • Description: Provider of biopharmaceutical development focused on human antibody therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Humanigen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for GlycoVaxyn

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to GlycoVaxyn

2.2 - Growth funds investing in similar companies to GlycoVaxyn

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for GlycoVaxyn

4.2 - Public trading comparable groups for GlycoVaxyn

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to GlycoVaxyn

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About GlycoVaxyn

What does GlycoVaxyn do?

GlycoVaxyn is a provider of biological conjugation vaccines against bacterial infections utilizing recombinant DNA technology, developing and manufacturing immunogenic glycoprotein conjugate vaccines for a range of bacterial diseases, including pneumococcal and nosocomial infections.

Who are GlycoVaxyn's competitors?

GlycoVaxyn's competitors and similar companies include Inhibikase Therapeutics, Ondine Biomedical, Quick-Med Technologies, SOM Biotech, and Humanigen.

Where is GlycoVaxyn headquartered?

GlycoVaxyn is headquartered in Switzerland.

How many employees does GlycoVaxyn have?

GlycoVaxyn has 1,000 employees 🔒.

When was GlycoVaxyn founded?

GlycoVaxyn was founded in 2010 🔒.

What sector and industry vertical is GlycoVaxyn in?

GlycoVaxyn is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for GlycoVaxyn

Who are the top strategic acquirers in GlycoVaxyn's sector and industry

Top strategic M&A buyers and acquirers in GlycoVaxyn's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for GlycoVaxyn?

Top strategic M&A buyers groups and sectors for GlycoVaxyn include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in GlycoVaxyn's sector and industry vertical

Which are the top PE firms investing in GlycoVaxyn's sector and industry vertical?

Top PE firms investing in GlycoVaxyn's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in GlycoVaxyn's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in GlycoVaxyn's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in GlycoVaxyn's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to GlycoVaxyn include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in GlycoVaxyn's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for GlycoVaxyn?

The key public trading comparables and valuation benchmarks for GlycoVaxyn include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for GlycoVaxyn for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for GlycoVaxyn with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in GlycoVaxyn's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for GlycoVaxyn with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in GlycoVaxyn's' sector and industry vertical?

Access recent funding rounds and capital raises in GlycoVaxyn's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for GlycoVaxyn